Bipolar transurethral resection of the prostate (TURP) in combination with high-intensity diode laser (DL + b-TURP) is feasible for treatment of benign prostatic hyperplasia (BPH) in large ...

Discover a study exploring how pyridostigmine may enhance symptom relief and bladder function in men with underactive bladder ...

Using the 2008-2021 American College of Surgeons National Surgical Quality Improvement Program database, investigators identified 83,020 patients who underwent TURP, LEP, or LVP to treat BPH.

Current BPH treatment with transurethral resection of the prostate (“TURP”) is largely unchanged over the past 100 years.

ProVerum’s ProVee system could offer patients a safe and effective treatment without the need for highly invasive surgery.

ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the closing of an $80 million Series B ...

ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stent-like implant to relieve the urinary symptoms of an enlarged prostat | The Dublin ...